Fact based stock research
COSMOS Pharmaceutical (TSE:3349)

JP3298400007

COSMOS Pharmaceutical stock research in summary

cosmospc.co.jp


COSMOS Pharmaceutical shares are less expensive than other comparable stocks. They are good value and are safely financed, but show below average growth. We recommend evaluating whether the future of the company COSMOS Pharmaceutical is really as difficult as the low price of the stock suggests. If you believe that the future of the company is market-typical or even better, then this could be an argument for a share purchase.


Latest Obermatt Ranks


Country Japan
Industry Drug Retail
Index
Size class X-Large

October 21, 2021. Stock data may be delayed. Login to get the most recent research.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for COSMOS Pharmaceutical from October 21, 2021.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.